Author: Butler, Daniel; Mozsary, Christopher; Meydan, Cem; Foox, Jonathan; Rosiene, Joel; Shaiber, Alon; Danko, David; Afshinnekoo, Ebrahim; MacKay, Matthew; Sedlazeck, Fritz J.; Ivanov, Nikolay A.; Sierra, Maria; Pohle, Diana; Zietz, Michael; Gisladottir, Undina; Ramlall, Vijendra; Sholle, Evan T.; Schenck, Edward J.; Westover, Craig D.; Hassan, Ciaran; Ryon, Krista; Young, Benjamin; Bhattacharya, Chandrima; Ng, Dianna L.; Granados, Andrea C.; Santos, Yale A.; Servellita, Venice; Federman, Scot; Ruggiero, Phyllis; Fungtammasan, Arkarachai; Chin, Chen-Shan; Pearson, Nathaniel M.; Langhorst, Bradley W.; Tanner, Nathan A.; Kim, Youngmi; Reeves, Jason W.; Hether, Tyler D.; Warren, Sarah E.; Bailey, Michael; Gawrys, Justyna; Meleshko, Dmitry; Xu, Dong; Couto-Rodriguez, Mara; Nagy-Szakal, Dorottya; Barrows, Joseph; Wells, Heather; O’Hara, Niamh B.; Rosenfeld, Jeffrey A.; Chen, Ying; Steel, Peter A. D.; Shemesh, Amos J.; Xiang, Jenny; Thierry-Mieg, Jean; Thierry-Mieg, Danielle; Iftner, Angelika; Bezdan, Daniela; Sanchez, Elizabeth; Campion, Thomas R.; Sipley, John; Cong, Lin; Craney, Arryn; Velu, Priya; Melnick, Ari M.; Shapira, Sagi; Hajirasouliha, Iman; Borczuk, Alain; Iftner, Thomas; Salvatore, Mirella; Loda, Massimo; Westblade, Lars F.; Cushing, Melissa; Wu, Shixiu; Levy, Shawn; Chiu, Charles; Schwartz, Robert E.; Tatonetti, Nicholas; Rennert, Hanna; Imielinski, Marcin; Mason, Christopher E.
Title: Shotgun transcriptome, spatial omics, and isothermal profiling of SARS-CoV-2 infection reveals unique host responses, viral diversification, and drug interactions Cord-id: c794ep1k Document date: 2021_3_12
ID: c794ep1k
Snippet: In less than nine months, the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) killed over a million people, including >25,000 in New York City (NYC) alone. The COVID-19 pandemic caused by SARS-CoV-2 highlights clinical needs to detect infection, track strain evolution, and identify biomarkers of disease course. To address these challenges, we designed a fast (30-minute) colorimetric test (LAMP) for SARS-CoV-2 infection from naso/oropharyngeal swabs and a large-scale shotgun metatran
Document: In less than nine months, the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) killed over a million people, including >25,000 in New York City (NYC) alone. The COVID-19 pandemic caused by SARS-CoV-2 highlights clinical needs to detect infection, track strain evolution, and identify biomarkers of disease course. To address these challenges, we designed a fast (30-minute) colorimetric test (LAMP) for SARS-CoV-2 infection from naso/oropharyngeal swabs and a large-scale shotgun metatranscriptomics platform (total-RNA-seq) for host, viral, and microbial profiling. We applied these methods to clinical specimens gathered from 669 patients in New York City during the first two months of the outbreak, yielding a broad molecular portrait of the emerging COVID-19 disease. We find significant enrichment of a NYC-distinctive clade of the virus (20C), as well as host responses in interferon, ACE, hematological, and olfaction pathways. In addition, we use 50,821 patient records to find that renin–angiotensin–aldosterone system inhibitors have a protective effect for severe COVID-19 outcomes, unlike similar drugs. Finally, spatial transcriptomic data from COVID-19 patient autopsy tissues reveal distinct ACE2 expression loci, with macrophage and neutrophil infiltration in the lungs. These findings can inform public health and may help develop and drive SARS-CoV-2 diagnostic, prevention, and treatment strategies.
Search related documents:
Co phrase search for related documents- absence presence and accuracy specificity sensitivity: 1, 2
- absence presence and accurate comprehensive: 1
- absence presence and ace expression: 1
- absence presence and acute phase: 1, 2, 3, 4, 5, 6, 7, 8
- absence presence and adaptive immunity: 1, 2, 3, 4
- absence presence and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63
- absence presence and low high medium: 1, 2
- absence presence and low incidence: 1, 2
- absence presence and low quality: 1, 2, 3
- absence presence and low significance: 1
- absence presence and lower right: 1, 2, 3
- absence presence and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- absence presence and lung material: 1
- absence presence and lung present: 1, 2, 3, 4
- absence presence and lung sample: 1
- absence presence and lung tissue: 1, 2, 3, 4, 5, 6, 7, 8
- absence presence and lung tissue present: 1
Co phrase search for related documents, hyperlinks ordered by date